NuVasive (NSDQ:NUVA) announced today that it received FDA approval for its Simplify disc in two-level cervical total disc replacement (cTDR). San Diego-based NuVasive’s Simplify cervical artificial disc, part of its NuVasive C360 portfolio, is comprised of PEEK on ceramic materials to allow for enhanced visualization through MRI postoperatively when compared to alternative devices, according to […]
Nuvasive
NuVasive reports mixed Q4 results
NuVasive (NASDAQ: NUVA) today reported Q4 earnings that beat the consensus forecast on Wall Street, but it came up short on revenue. The San Diego–based spine tech company earned $1.7 million, or 3¢ per share, on sales of $291.8 million for the three months ended Dec. 31, 2020, for a bottom-line drop of –94% on […]
NuVasive acquires Simplify Medical in $150M deal
NuVasive (NSDQ:NUVA) yesterday announced that it has acquired Simplify Medical for $150 million. Through the deal, NuVasive made an upfront payment of $150 million at closing using cash on hand, subject to customary purchase price adjustments. The company agreed to make additional future payments contingent upon milestones related to regulatory approval and net sales. Simplify Medical […]
NuVasive updates scoliosis device recall
NuVasive (NSDQ:NUVA) issued a voluntary field safety notice in Europe to warn of an issue with its Magec scoliosis treatment device. The Magec system is a metallic spinal implant designed for bracing the spine during growth to minimize the progression of scoliosis. Instructions for use of the device indicate that the implants can loosen, fracture, corrode, […]
NuVasive launches anterior cervical plate
NuVasive today launched its C360 cervical spine portfolio with its Anterior Cervical Plating system. The system features a thin plate measuring 1.6mm and is designed to reduce common postoperative complications like dysphagia, malalignment and adjacent level ossification to allow surgeons to customize treatment to patient needs. “The unveiling of the C360 portfolio reflects NuVasive’s commitment […]
Medtech and COVID-19: 7 things you need to know
When COVID-19 set upon the U.S. in March, medtech executives only had a month at most to explain to analysts in quarterly calls how the pandemic was hitting their companies — not nearly enough time to understand the long-term impact. Three more months have passed since those quarterly calls, and we’re now wrapping up a […]
NuVasive dips despite Street-beating Q2
NuVasive (NSDQ:NUVA) shares closed today on the downturn despite second-quarter results that beat the consensus forecast. The San Diego-based spine surgery technology developer posted losses of -$50 million, or -98¢ per share, on sales of $203.6 million for the three months ended June 30, 2020, for a bottom-line slide from profits of nearly $15 million year-over-year […]
NuVasive projecting losses up to $40m for Q2
NuVasive (NSDQ:NUVA) announced that it anticipates losses for the second quarter to come in around -$40 million amid the COVID-19 pandemic. The San Diego-based spine surgery technology developer said in a news release that preliminary results for the quarter, ended June 30, 2020, revealed an operating loss of between -$35 million and -$40 million on a […]
NuVasive launches pediatric spinal deformity device
NuVasive (NSDQ:NUVA) announced today that it launched its Reline 3D posterior fixation system for pediatric spinal deformities. San Diego-based NuVasive’s latest addition to its spine portfolio is now commercially available around the globe for treating adolescent idiopathic scoliosis (AIS). The Reline 3D is designed to turn a multi-step technique into a holistic, single-plane correction to offer […]
Nuvasive announces $400m offering
NuVasive (NSDQ:NUVA) announced that it intends to offer $400 million aggregate principal amount of convertible senior notes in a private offering. The San Diego-based spine technology company is offering the notes, due in 2023, as well as granting initial purchasers a 13-day option to purchase up to an additional $50 million in notes. According to a […]
NuVasive lands 2 510(k)s, launches spinal surgery device
NuVasive (NSDQ:NUVA) announced that it received FDA 510(k) clearance for its Modulus ALIF and Cohere TLIF-O offerings for thoracolumbar procedures. The San Diego-based company expanded its Advanced Materials Science (AMS) implant portfolio with the clearances, along with the commercial launch of the Modulus extreme lateral interbody fusion (XLIF) dual-sided plate. NuVasive’s Modulus anterior lumbar interbody fusion (ALIF) […]
